• Published On : Oct-2017 |
  • Pages : 273 Pages |
  • Format :

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. MicroRNA Market View Point 
   3.1. Macro-Economic Factors
   3.2. Opportunities
   3.3. Technology Assessment Analysis

4. North America MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Trends
   4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        4.5.1. Immunoassay
               4.5.1.1. Fluorescent Assays
               4.5.1.2. Colorimetric Assays
               4.5.1.3. Chemiluminescent Assays
        4.5.2. Next Generation Sequencing (NGS)
        4.5.3. miRNA Arrays
        4.5.4. PCR-based Assay
   4.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
        4.6.1. Immunoassay
               4.6.1.1. Fluorescent Assays
               4.6.1.2. Colorimetric Assays
               4.6.1.3. Chemiluminescent Assays
        4.6.2. Next Generation Sequencing (NGS)
        4.6.3. miRNA Arrays
        4.6.4. PCR-based Assay
   4.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        4.7.1. Research
        4.7.2. Clinical Diagnostics
   4.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
        4.8.1. Research
        4.8.2. Clinical Diagnostics
   4.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
        4.9.1. Academic and Research Institutes
        4.9.2. Biopharmaceutical Companies
        4.9.3. Contract Research Organizations
        4.9.4. Diagnostic Centers
   4.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
        4.10.1. Academic and Research Institutes
        4.10.2. Biopharmaceutical Companies
        4.10.3. Contract Research Organizations
        4.10.4. Diagnostic Centers
   4.11. Drivers and Restraints: Impact Analysis
   4.12. Market Attractiveness Analysis
        4.12.1. By Country
        4.12.2. By Assay Type
        4.12.3. By Application 
        4.12.4. By End User  
   4.13. North America MicroRNA Key Participants Market Presence (Intensity Map)

5. Latin America MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Regional Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Trends
   5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        5.3.1. Brazil
        5.3.2. Mexico
        5.3.3. Rest of Latin America
   5.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Rest of Latin America
   5.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        5.5.1. Immunoassay
               5.5.1.1. Fluorescent Assays
               5.5.1.2. Colorimetric Assays
               5.5.1.3. Chemiluminescent Assays
        5.5.2. Next Generation Sequencing (NGS)
        5.5.3. miRNA Arrays
        5.5.4. PCR-based Assay
   5.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
        5.6.1. Immunoassay
               5.6.1.1. Fluorescent Assays
               5.6.1.2. Colorimetric Assays
               5.6.1.3. Chemiluminescent Assays
        5.6.2. Next Generation Sequencing (NGS)
        5.6.3. miRNA Arrays
        5.6.4. PCR-based Assay
   5.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        5.7.1. Research
        5.7.2. Clinical Diagnostics
   5.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
        5.8.1. Research
        5.8.2. Clinical Diagnostics
   5.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
        5.9.1. Academic and Research Institutes
        5.9.2. Biopharmaceutical Companies
        5.9.3. Contract Research Organizations
        5.9.4. Diagnostic Centers
   5.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
        5.10.1. Academic and Research Institutes
        5.10.2. Biopharmaceutical Companies
        5.10.3. Contract Research Organizations
        5.10.4. Diagnostic Centers
   5.11. Drivers and Restraints: Impact Analysis
   5.12. Market Attractiveness Analysis
        5.12.1. By Country
        5.12.2. By Assay Type
        5.12.3. By Application 
        5.12.4. By End User  
   5.13. Latin America MicroRNA Key Participants Market Presence (Intensity Map)

6. Europe MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Regional Market Dynamics
        6.2.1. Drivers
        6.2.2. Restraints
        6.2.3. Trends
   6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        6.3.1. Germany
        6.3.2. UK
        6.3.3. France
        6.3.4. Italy
        6.3.5. Spain
        6.3.6. Russia
        6.3.7. Rest of Europe
   6.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        6.4.1. Germany
        6.4.2. UK
        6.4.3. France
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. Russia
        6.4.7. Rest of Europe
   6.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        6.5.1. Immunoassay
               6.5.1.1. Fluorescent Assays
               6.5.1.2. Colorimetric Assays
               6.5.1.3. Chemiluminescent Assays
        6.5.2. Next Generation Sequencing (NGS)
        6.5.3. miRNA Arrays
        6.5.4. PCR-based Assay
   6.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
        6.6.1. Immunoassay
               6.6.1.1. Fluorescent Assays
               6.6.1.2. Colorimetric Assays
               6.6.1.3. Chemiluminescent Assays
        6.6.2. Next Generation Sequencing (NGS)
        6.6.3. miRNA Arrays
        6.6.4. PCR-based Assay
   6.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        6.7.1. Research
        6.7.2. Clinical Diagnostics
   6.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
        6.8.1. Research
        6.8.2. Clinical Diagnostics
   6.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
        6.9.1. Academic and Research Institutes
        6.9.2. Biopharmaceutical Companies
        6.9.3. Contract Research Organizations
        6.9.4. Diagnostic Centers
   6.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
        6.10.1. Academic and Research Institutes
        6.10.2. Biopharmaceutical Companies
        6.10.3. Contract Research Organizations
        6.10.4. Diagnostic Centers
   6.11. Drivers and Restraints: Impact Analysis
   6.12. Market Attractiveness Analysis
        6.12.1. By Country
        6.12.2. By Assay Type
        6.12.3. By Application 
        6.12.4. By End User  
   6.13. Europe MicroRNA Key Participants Market Presence (Intensity Map)

7. Asia Pacific MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Regional Market Dynamics
        7.2.1. Drivers
        7.2.2. Restraints
        7.2.3. Trends
   7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        7.3.1. China
        7.3.2. India
        7.3.3. Japan
        7.3.4. Australia and New Zealand
        7.3.5. Rest of Asia Pacific
   7.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. Rest of Asia Pacific
   7.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        7.5.1. Immunoassay
               7.5.1.1. Fluorescent Assays
               7.5.1.2. Colorimetric Assays
               7.5.1.3. Chemiluminescent Assays
        7.5.2. Next Generation Sequencing (NGS)
        7.5.3. miRNA Arrays
        7.5.4. PCR-based Assay
   7.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
        7.6.1. Immunoassay
               7.6.1.1. Fluorescent Assays
               7.6.1.2. Colorimetric Assays
               7.6.1.3. Chemiluminescent Assays
        7.6.2. Next Generation Sequencing (NGS)
        7.6.3. miRNA Arrays
        7.6.4. PCR-based Assay
   7.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        7.7.1. Research
        7.7.2. Clinical Diagnostics
   7.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
        7.8.1. Research
        7.8.2. Clinical Diagnostics
   7.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
        7.9.1. Academic and Research Institutes
        7.9.2. Biopharmaceutical Companies
        7.9.3. Contract Research Organizations
        7.9.4. Diagnostic Centers
   7.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
        7.10.1. Academic and Research Institutes
        7.10.2. Biopharmaceutical Companies
        7.10.3. Contract Research Organizations
        7.10.4. Diagnostic Centers
   7.11. Drivers and Restraints: Impact Analysis
   7.12. Market Attractiveness Analysis
        7.12.1. By Country
        7.12.2. By Assay Type
        7.12.3. By Application 
        7.12.4. By End User  
   7.13. Asia Pacific MicroRNA Key Participants Market Presence (Intensity Map)

8. Middle East & Africa MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Regional Market Dynamics
        8.2.1. Drivers
        8.2.2. Restraints
        8.2.3. Trends
   8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        8.3.1. GCC Countries
        8.3.2. South Africa
        8.3.3. Rest of MEA
   8.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Rest of MEA
   8.5. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        8.5.1. Immunoassay
               8.5.1.1. Fluorescent Assays
               8.5.1.2. Colorimetric Assays
               8.5.1.3. Chemiluminescent Assays
        8.5.2. Next Generation Sequencing (NGS)
        8.5.3. miRNA Arrays
        8.5.4. PCR-based Assay
   8.6. Market Size (US$ Mn) Forecast By Assay Type, 2017–2025
        8.6.1. Immunoassay
               8.6.1.1. Fluorescent Assays
               8.6.1.2. Colorimetric Assays
               8.6.1.3. Chemiluminescent Assays
        8.6.2. Next Generation Sequencing (NGS)
        8.6.3. miRNA Arrays
        8.6.4. PCR-based Assay
   8.7. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        8.7.1. Research
        8.7.2. Clinical Diagnostics
   8.8. Market Size (US$ Mn) Forecast By Application, 2017–2025
        8.8.1. Research
        8.8.2. Clinical Diagnostics
   8.9. Historical Market Size (US$ Mn) Trend Analysis By End User , 2012–2016
        8.9.1. Academic and Research Institutes
        8.9.2. Biopharmaceutical Companies
        8.9.3. Contract Research Organizations
        8.9.4. Diagnostic Centers
   8.10. Market Size (US$ Mn) Forecast By End User , 2017–2025
        8.10.1. Academic and Research Institutes
        8.10.2. Biopharmaceutical Companies
        8.10.3. Contract Research Organizations
        8.10.4. Diagnostic Centers
   8.11. Drivers and Restraints: Impact Analysis
   8.12. Market Attractiveness Analysis
        8.12.1. By Country
        8.12.2. By Assay Type
        8.12.3. By Application 
        8.12.4. By End User  
   8.13. Middle East & Africa MicroRNA Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
   11.1. Competition Dashboard
   11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
        11.2.1. Illumina, Inc.
        11.2.2. F. Hoffmann-La Roche Ltd
        11.2.3. Agilent Technologies
        11.2.4. Bio-Rad Laboratories Inc.
        11.2.5. Sigma Aldrich Corp.
        11.2.6. Qiagen N.V
        11.2.7. Thermo Fisher Scientific, Inc.
        11.2.8. HTG Molecular Diagnostics, Inc.
        11.2.9. Bioline GmbH (A Meridian Life Science Company)
        11.2.10. Rosetta Genomics Ltd.
        11.2.11. Dharmacon, a Horizon Discovery Group Co.
        11.2.12. BioVendor — Laboratorní medicína a.s.
        11.2.13. Miltenyi Biotec
        11.2.14. Kaneka Corporation (Eurogentec)
        11.2.15. Abcam Plc
        11.2.16. GeneCopoeia, Inc.
        11.2.17. Promega Corporation
        11.2.18. New England Biolabs, Inc.
        11.2.19. NanoString Technologies, Inc.
        11.2.20. System Biosciences LLC

12. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   12.1. Introduction
   12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
        12.2.1. North America
        12.2.2. Latin America
        12.2.3. Europe
        12.2.4. Asia Pacific 
        12.2.5. Middle East & Africa
   12.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
        12.3.1. North America
        12.3.2. Latin America
        12.3.3. Europe
        12.3.4. Asia Pacific 
        12.3.5. Middle East & Africa
   12.4. Market Attractiveness Analysis By Region

13. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Assay Type
   13.1. Introduction
   13.2. Historical Market Size (US$ Mn) Trend Analysis By Assay Type , 2012–2016
        13.2.1. Immunoassay
               13.2.1.1. Fluorescent Assays
               13.2.1.2. Colorimetric Assays
               13.2.1.3. Chemiluminescent Assays
        13.2.2. Next Generation Sequencing (NGS)
        13.2.3. miRNA Arrays
        13.2.4. PCR-based Assay
   13.3. Market Size (US$ Mn) and Forecast By Assay Type, 2017–2025
        13.3.1. Immunoassay
               13.3.1.1. Fluorescent Assays
               13.3.1.2. Colorimetric Assays
               13.3.1.3. Chemiluminescent Assays
        13.3.2. Next Generation Sequencing (NGS)
        13.3.3. miRNA Arrays
        13.3.4. PCR-based Assay
   13.4. Market Attractiveness Analysis By Assay Type

14. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By Application
   14.1. Introduction
   14.2. Historical Market Size (US$ Mn) Trend Analysis By Application , 2012–2016
        14.2.1. Research
        14.2.2. Clinical Diagnostics
   14.3. Market Size (US$ Mn) and Forecast By Application, 2017–2025
        14.3.1. Research
        14.3.2. Clinical Diagnostics
   14.4. Market Attractiveness Analysis By Application

15. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025, By End User
   15.1. Introduction
   15.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
        15.2.1. Academic and Research Institutes
        15.2.2. Biopharmaceutical Companies
        15.2.3. Contract Research Organizations
        15.2.4. Diagnostic Centers
   15.3. Market Size (US$ Mn) Forecast By End User, 2017–2025
        15.3.1. Academic and Research Institutes
        15.3.2. Biopharmaceutical Companies
        15.3.3. Contract Research Organizations
        15.3.4. Diagnostic Centers
   15.4. Market Attractiveness Analysis By End User

16. Global MicroRNA Market Analysis 2012–2016 and Forecast 2017–2025
   16.1. Market Size and Y-o-Y Growth
   16.2. Absolute $ Opportunity


List of Tables

Table 01: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 02: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 03: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 04: North America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 05: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 06: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 07: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 08: Latin America MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 09: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 10: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 11: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 12: Europe MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 13: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 14: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 15: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 16: Asia Pacific MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 17: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 18: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 19: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 20: MEA MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 21: Global MicroRNA Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025, By Region 
Table 22: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Assay Type
Table 23: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Applications
Table 24: Global MicroRNA Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User


List of Figures

Figure 01: North America MicroRNA Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 02: North America MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 03: U.S. MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 04: U.S. MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 05: Canada MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 06: Canada MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 07: North America MicroRNA Market Attractiveness Analysis By Country, 2017–2025
Figure 08: North America MicroRNA Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 09: North America MicroRNA NGS Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: North America miRNA Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 11: North America MicroRNA PCR Based Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: North America Fluorescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 13: North America Colorimetric Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: North America Chemiluminescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 15: North America MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 16: North America MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 17: North America MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 18: North America MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 19: North America MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 20: North America MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 21: North America MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 22: North America MicroRNA Academic & Research Institutes Market Size (US$ Mn) Analysis, 2012–2016
Figure 23: North America MicroRNA Biopharmaceutical Companies Market Size (US$ Mn) Analysis, 2012–2016
Figure 24: North America MicroRNA Diagnostic Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 25: North America MicroRNA Clinical Research Organizations Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: North America MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 27: Latin America MicroRNA Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 28: Latin America MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 29: Brazil MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 30: Brazil MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 31: Mexico MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 32: Mexico MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 33: Rest of Latin America MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 34: Rest of Latin America MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 35: Latin America MicroRNA Market Attractiveness Analysis By Country, 2017–2025
Figure 36: Latin America MicroRNA Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 37: Latin America MicroRNA NGS Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Latin America miRNA Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 39: Latin America MicroRNA PCR Based Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: Latin America Fluorescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 41: Latin America Colorimetric Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Latin America Chemiluminescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 43: Latin America MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 44: Latin America MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 45: Latin America MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 46: Latin America MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 47: Latin America MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 48: Latin America MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 49: Latin America MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 50: Latin America MicroRNA Academic & Research Institutes Market Size (US$ Mn) Analysis, 2012–2016
Figure 51: Latin America MicroRNA Biopharmaceutical Companies Market Size (US$ Mn) Analysis, 2012–2016
Figure 52: Latin America MicroRNA Diagnostic Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 53: Latin America MicroRNA Clinical Research Organizations Market Size (US$ Mn) Analysis, 2012–2016
Figure 54: Latin America MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 55: Europe MicroRNA Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 56: Europe MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 57: Germany MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 58: Germany MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 59: UK MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 60: UK MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 61: Brazil MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 62: Brazil MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 63: Italy MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 64: Italy MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 65: Spain MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: Spain MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 67: Russia MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: Russia MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 69: Rest of Europe MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: Rest of Europe MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 71: Europe MicroRNA Market Attractiveness Analysis By Country, 2017–2025
Figure 72: Europe MicroRNA Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 73: Europe MicroRNA NGS Market Size (US$ Mn) Analysis, 2012–2016
Figure 74: Europe miRNA Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 75: Europe MicroRNA PCR Based Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 76: Europe Fluorescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 77: Europe Colorimetric Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 78: Europe Chemiluminescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 79: Europe MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 80: Europe MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 81: Europe MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 82: Europe MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 83: Europe MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 84: Europe MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 85: Europe MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 86: Europe MicroRNA Academic & Research Institutes Market Size (US$ Mn) Analysis, 2012–2016
Figure 87: Europe MicroRNA Biopharmaceutical Companies Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: Europe MicroRNA Diagnostic Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 89: Europe MicroRNA Clinical Research Organizations Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: Europe MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 91: Asia Pacific MicroRNA Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 92: Asia Pacific MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 93: China MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 94: China MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 95: India MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 96: India MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 97: Japan MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 98: Japan MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 99: Australia and New Zealand MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 100: Australia and New Zealand MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 101: Rest of Asia Pacific MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 102: Rest of Asia Pacific MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 103: Asia Pacific MicroRNA Market Attractiveness Analysis By Country, 2017–2025
Figure 104: Asia Pacific MicroRNA Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 105: Asia Pacific MicroRNA NGS Market Size (US$ Mn) Analysis, 2012–2016
Figure 106: Asia Pacific miRNA Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 107: Asia Pacific MicroRNA PCR Based Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 108: Asia Pacific Fluorescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 109: Asia Pacific Colorimetric Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 110: Asia Pacific Chemiluminescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 111: Asia Pacific MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 112: Asia Pacific MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 113: Asia Pacific MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 114: Asia Pacific MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 115: Asia Pacific MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 116: Asia Pacific MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 117: Asia Pacific MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 118: Asia Pacific MicroRNA Academic & Research Institutes Market Size (US$ Mn) Analysis, 2012–2016
Figure 119: Asia Pacific MicroRNA Biopharmaceutical Companies Market Size (US$ Mn) Analysis, 2012–2016
Figure 120: Asia Pacific MicroRNA Diagnostic Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 121: Asia Pacific MicroRNA Clinical Research Organizations Market Size (US$ Mn) Analysis, 2012–2016
Figure 122: Asia Pacific MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 123: MEA MicroRNA Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 124: MEA MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 125: GCC Countries MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 126: GCC Countries MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 127: South Africa MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 128: South Africa MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 129: Rest of MEA MicroRNA Market Size (US$ Mn) Analysis, 2012–2016
Figure 130: Rest of MEA MicroRNA Market Size (US$ Mn) Forecast, 2017–2025
Figure 131: MEA MicroRNA Market Attractiveness Analysis By Country, 2017–2025
Figure 132: MEA MicroRNA Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 133: MEA MicroRNA NGS Market Size (US$ Mn) Analysis, 2012–2016
Figure 134: MEA miRNA Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 135: MEA MicroRNA PCR Based Arrays Market Size (US$ Mn) Analysis, 2012–2016
Figure 136: MEA Fluorescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 137: MEA Colorimetric Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 138: MEA Chemiluminescent Immunoassay Market Size (US$ Mn) Analysis, 2012–2016
Figure 139: MEA MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 140: MEA MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 141: MEA MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 142: MEA MicroRNA Research Market Size (US$ Mn) Analysis, 2012–2016
Figure 143: MEA MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 144: MEA MicroRNA Clinical Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 145: MEA MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 146: MEA MicroRNA Academic & Research Institutes Market Size (US$ Mn) Analysis, 2012–2016
Figure 147: MEA MicroRNA Biopharmaceutical Companies Market Size (US$ Mn) Analysis, 2012–2016
Figure 148: MEA MicroRNA Diagnostic Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 149: MEA MicroRNA Clinical Research Organizations Market Size (US$ Mn) Analysis, 2012–2016
Figure 150: MEA MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 151:  Global MicroRNA Market Y-o-Y Growth (%) Analysis 2017-2025, By Region
Figure 152:  Global MicroRNA Market Attractiveness Analysis By Region, 2017–2025
Figure 153: Global MicroRNA Market Y-o-Y Analysis By Assay Type, 2017 - 2025
Figure 154: Global MicroRNA Market Attractiveness Analysis By Assay Type, 2017–2025
Figure 155: Global MicroRNA Market Attractiveness Analysis By Immunoassay Type, 2017–2025
Figure 156: Global MicroRNA Market Y-o-Y Analysis By Applications, 2017 - 2025
Figure 157: Global MicroRNA Market Attractiveness Analysis By Applications, 2017–2025
Figure 158: Global MicroRNA Market Y-o-Y Growth (%) Analysis By End User, 2017 & 2025
Figure 159: Global MicroRNA Market Attractiveness Analysis By End User, 2017–2025
Figure 160: Global MicroRNA Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 161: Global MicroRNA Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 162: Global MicroRNA Market Absolute $ Opportunity (US$ Mn), 2016–2025